Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow AMARIN CORP PLC\UK

Get SEC filing alerts via email and in your feed for AMARIN CORP PLC\UK

AMRN

AMARIN CORP PLC\UK

About AMARIN CORP PLC\UK

Amarin Corporation plc is a pharmaceutical company dedicated to improving cardiovascular health through its flagship product, VASCEPA (icosapent ethyl). Approved for reducing triglyceride levels and cardiovascular risk, VASCEPA targets high-risk patients, with significant market potential in the U.S. and Europe. The company is expanding its global reach through strategic partnerships and regulatory approvals, while implementing cost-reduction initiatives to enhance operational efficiency and focus on growth.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from AMARIN CORP PLC\UK

1
1
AMARIN CORP PLC\UK Amarin Corporation Reports 7.4% Revenue Growth and Improved Net Loss in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
AMARIN CORP PLC\UK Amarin Corporation Reports $213.6 Million Revenue for Fiscal Year 2025, Down 7% from 2024

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
AMARIN CORP PLC\UK Amarin Corporation Reports 17% Revenue Growth in Q3 2025, Net Loss Improves

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
AMARIN CORP PLC\UK Amarin Corporation Reports 8% Revenue Growth but Net Loss of $14.1 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
AMARIN CORP PLC\UK Amarin Corporation Reports 26% Revenue Decline and Increased Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
AMARIN CORP PLC\UK Amarin Corporation Reports 26% Revenue Decline to $228.6 Million for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
AMARIN CORP PLC\UK Amarin Corporation Reports 36% Decline in Revenue, Reduced Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments